Karen M. Grant

Karen M. Grant

Auto-generated profile, based on publicly available information

Karen M. Grant

Faculty of Health and Medicine, Lancaster Medical School, Lancaster University, LA1 4YA, UK

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2000 in Chemistry & Biology
Verified
Journal Article
Closed access
MKM Knockaert
M Knockaert
NGN Gray
N Gray
EDE Damiens
E Damiens
YCYoung-Tae Chang
Young-Tae Chang
PGP Grellier
P Grellier
LML Meijer
L Meijer

1 July 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MKMarie Knockaert
Marie Knockaert
KWKaren Wieking
Karen Wieking
SSSophie Schmitt
Sophie Schmitt
MLMaryse Leost
Maryse Leost
KGKaren M. Grant
Karen M. Grant
LMLaurent Meijer
Laurent Meijer
Numerous inhibitors of cyclin-dependent kinases and glycogen synthase kinase-3 (GSK-3) are being developed in view of their potential applications against cancers and neurodegenerative disorders. Among these, paullones constitute a family of potent and apparently selective cyclin-dependent kinase and GSK-3 inhibitors. However, their actual intracellular targets remain to be identified. To address this issue we have immobilized a paullone, gwennpaullone, on an agarose matrix. Extracts from various cell types and tissues were screened for proteins interacting with this matrix. This approach validated GSK-3α and GSK-3β as major intracellular paullone targets and also mitochondrial, but not cytoplasmic, malate dehydrogenase (MDH). Mitochondrial MDH was indeed inhibited by micromolar concentrations of paullones. Mitochondrial MDH was the major paullone-binding protein in the parasitic protozoon Leishmania mexicana, and paullones inhibited growth of the parasite. This simple batchwise affinity chromatography approach constitutes a straightforward method for the identification of intracellular targets of this particular class of novel anti-mitotic compounds. It has revealed an unexpected target, mitochondrial MDH, the inhibition of which may participate in the pharmacological effects of paullones.

1 April 2001 in Molecular and Biochemical Parasitology
Verified
Journal Article
Closed access
PHPaul Hassan
Paul Hassan
DFDavid Fergusson
David Fergusson
KGKaren M. Grant
Karen M. Grant
JMJeremy C. Mottram
Jeremy C. Mottram

1 August 2004 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
KGKaren M. Grant
Karen M. Grant
MDMorag H. Dunion
Morag H. Dunion
VYVanessa Yardley
Vanessa Yardley
ASAlexios-Leandros Skaltsounis
Alexios-Leandros Skaltsounis
Doris MarkoDoris Marko
Doris Marko
JMJeremy C. Mottram
Jeremy C. Mottram
The CRK3 cyclin-dependent kinase of Leishmania has been shown by genetic manipulation of the parasite to be essential for proliferation. We present data which demonstrate that chemical inhibition of CRK3 impairs the parasite's viability within macrophages, thus further validating CRK3 as a potential drug target. A microtiter plate-based histone H1 kinase assay was developed to screen CRK3 against a chemical library enriched for protein kinase inhibitors. Twenty-seven potent CRK3 inhibitors were discovered and screened against Leishmania donovani amastigotes in vitro. Sixteen of the CRK3 inhibitors displayed antileishmanial activity, with a 50% effective dose (ED 50 ) of less than 10 μM. These compounds fell into four chemical classes: the 2,6,9-trisubstituted purines, including the C-2-alkynylated purines; the indirubins; the paullones; and derivatives of the nonspecific kinase inhibitor staurosporine. The paullones and staurosporine derivatives were toxic to macrophages. The 2,6,9-trisubstituted purines inhibited CRK3 in vitro, with 50% inhibitory concentrations ranging from high nanomolar to low micromolar concentrations. The most potent inhibitors of CRK3 (compounds 98/516 and 97/344) belonged to the indirubin class; the 50% inhibitory concentrations for these inhibitors were 16 and 47 nM, respectively, and the ED 50 s for these inhibitors were 5.8 and 7.6 μM, respectively. In culture, the indirubins caused growth arrest, a change in DNA content, and aberrant cell types, all consistent with the intracellular inhibition of a cyclin-dependent kinase and disruption of cell cycle control. Thus, use of chemical inhibitors supports genetic studies to confirm CRK3 as a validated drug target in Leishmania and provides pharmacophores for further drug development.

1 October 2009 in International Journal for Parasitology
Verified
Journal Article
Closed access
EXEvangelia Xingi
Evangelia Xingi
DSDespina Smirlis
Despina Smirlis
VMVassilios Myrianthopoulos
Vassilios Myrianthopoulos
Prokopios MagiatisProkopios Magiatis
Prokopios Magiatis
KGKaren M. Grant
Karen M. Grant
KSKetty Soteriadou
Ketty Soteriadou

15 July 2009 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
SAShashini C Arambage
Shashini C Arambage
KGKaren M Grant
Karen M Grant
IPIan Pardo
Ian Pardo
LRLisa Ranford-Cartwright
Lisa Ranford-Cartwright
HHHilary Hurd
Hilary Hurd
Background: A wide range of unicellular eukaryotes have now been shown to undergo a form of programmed cell death (PCD) that resembles apoptosis; exhibiting morphological and, in some cases, biochemical markers typical of metazoans. However, reports that sexual and asexual stages of malaria parasites exhibit these markers have been challenged. Here we use a rodent malaria model, Plasmodium berghei, to determine whether, and what proportion of cultured ookinetes show signs of apoptosis-like death and extend the study to examine ookinetes of Plasmodium falciparum in vivo. Results: Ookinetes displayed the following markers of PCD: loss of mitochondrial membrane potential, nuclear chromatin condensation, DNA fragmentation, translocation of phosphatidylserine to the outer surface of the cell membrane and caspase-like activity. The proportion of parasites expressing apoptosis markers rose with time, particularly when cultured in phosphate buffered saline. Some ookinetes positive for apoptosis markers also had compromised membranes, which could represent a late stage in the process. When these are included a similar proportion of ookinetes display each marker. Over 50% of P. falciparum ookinetes, removed from the mosquito midgut lumen 24 h post-infection, had nuclei containing fragmented DNA. Conclusion: We have confirmed previous reports that Plasmodium ookinetes display multiple signs that suggest they die by a mechanism resembling apoptosis. This occurs in vivo and in vitro without experimental application of triggers. Our findings support the hypothesis that non-necrotic mechanisms of cell death evolved before the advent of multicellular organisms.